Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

China approves ethics advisory group after CRISPR-babies scandal

Bioethicists hope a national committee will help close loopholes in the country’s biomedical ethics regulations.
  1. Hepeng Jia
    View author publications

    You can also search for this author in PubMed  Google Scholar

China will establish a national committee to advise the government on research-ethics regulations. The decision comes less than a year after a Chinese scientist sparked an international outcry over claims that he had created the world’s first genome-edited babies.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-019-02362-5

Updates & Corrections

  • Clarification 08 August 2019: This article has been updated to make clear that He Jiankui's ethics review approval was found to be fake after an investigation by the Guangdong health ministry. And to clarify that He's informed consent is considered invalid by bioethicists, not by the health ministry.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links